Patents by Inventor Edmond Rambod

Edmond Rambod has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9402941
    Abstract: A continuous renal replacement therapy (CRRT) device is provided that weighs between 2 and 10 pounds. The CRRT device can be portable, mobile or completely worn on the person of the patient. Blood and dialysate are each pumped in a pulsed or pulsatile manner through a dialyzer such that a significant portion of the peak pulse of the blood flow coincides with a significant portion of a low pulse portion of the dialysate flow. An differential pressure between a dialysate inlet of the dialyzer and the blood inlet of the dialyzer periodically changes from a high differential pressure of between 70 and 120 mmHg for a first time period and a low differential pressure of between ?10 and 10 mmHg for a first time period and a low differential pressure of between ?10 and 10 mmHg for a second time period. The frequency of the high and low differential pressure cycle is between about 0.5 and 4 Hz.
    Type: Grant
    Filed: January 10, 2014
    Date of Patent: August 2, 2016
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventors: Edmond Rambod, Victor Gura
  • Publication number: 20140175010
    Abstract: A continuous renal replacement therapy (CRRT) device is provided that weighs between 2 and 10 pounds. The CRRT device can be portable, mobile or completely worn on the person of the patient. Blood and dialysate are each pumped in a pulsed or pulsatile manner through a dialyzer such that a significant portion of the peak pulse of the blood flow coincides with a significant portion of a low pulse portion of the dialysate flow. An differential pressure between a dialysate inlet of the dialyzer and the blood inlet of the dialyzer periodically changes from a high differential pressure of between 70 and 120 mmHg for a first time period and a low differential pressure of between ?10 and 10 mmHg for a first time period and a low differential pressure of between ?10 and 10 mmHg for a second time period. The frequency of the high and low differential pressure cycle is between about 0.5 and 4 Hz.
    Type: Application
    Filed: January 10, 2014
    Publication date: June 26, 2014
    Applicant: Fresenius Medical Care Holdings, Inc.
    Inventors: Edmond Rambod, Victor Gura
  • Patent number: 8641655
    Abstract: A continuous renal replacement therapy (CRRT) device is provided that weighs between 2 and 10 pounds. The CRRT device can be portable, mobile or completely worn on the person of the patient. Blood and dialysate are each pumped in a pulsed or pulsatile manner through a dialyzer such that a significant portion of the peak pulse of the blood flow coincides with a significant portion of a low pulse portion of the dialysate flow. An differential pressure between a dialysate inlet of the dialyzer and the blood inlet of the dialyzer periodically changes from a high differential pressure of between 70 and 120 mmHg for a first time period and a low differential pressure of between ?10 and 10 mmHg for a first time period and a low differential pressure of between ?10 and 10 mmHg for a second time period. The frequency of the high and low differential pressure cycle is between about 0.5 and 4 Hz.
    Type: Grant
    Filed: December 23, 2010
    Date of Patent: February 4, 2014
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventors: Edmond Rambod, Victor Gura
  • Patent number: 8622909
    Abstract: This invention relates to diagnostic and screening medical ultrasound in general and to ultrasound-stimulated detection and location, Image-based Dynamic Ultrasound Spectrography, Acoustic Radiation Force Imaging, and similar modalities in particular. In this invention, an ultrasound signal is emitted into tissue and the resulting radiation force induces localized lower frequency oscillations, which are then received by various acoustic sensors and analyzed to determine certain features or characteristics of the interrogated region. The sensors can be arranged in the form of a ring, in any random arrangements, or positioned in specifically chosen locations. An ultrasonic imaging and excitation transducer generates certain stimulating signals which are received by the breast tissues and which, if they contact a microcalcification, other target, or any region with sharply different mechanical and visco-elastic properties, will result in reflected, demodulated, or re-radiated signals.
    Type: Grant
    Filed: October 19, 2010
    Date of Patent: January 7, 2014
    Assignee: Quantason, LLC
    Inventors: Joseph J. O'Ruanaidh, Christopher J. Vecchio, Edmond Rambod
  • Patent number: 8376947
    Abstract: A method for the detection and localization of breast microcalcification through a precise method of ultrasound impacting and ultrasound frequency wave detection which will enable the system to detect not only if there is a microcalcification in the breast, but the precise location of the microcalcification and the mass of the microcalcification. The invention is also a method and system that provides bi-modal guided stimulation of a targeted mass within the breast to determine the location and nature of the microcalcification within the breast.
    Type: Grant
    Filed: March 26, 2008
    Date of Patent: February 19, 2013
    Assignee: Bioquantetics, Inc.
    Inventors: Edmond Rambod, Yacov Itzchak, Ari Shamiss, Daniel Weihs
  • Patent number: 8372006
    Abstract: The present invention is a method for detecting and locating a target using phase information obtained from an array of microphones or other sensors.
    Type: Grant
    Filed: June 16, 2010
    Date of Patent: February 12, 2013
    Assignee: Quantason, LLC
    Inventors: Joseph O'Ruanaidh, Christopher J. Vecchio, Edmond Rambod
  • Patent number: 8206331
    Abstract: An ultrafiltration device adapted to be worn on a portion of the body of a patient includes a blood inlet tube leading from a first blood vessel, a blood pump, an anticoagulant reservoir for infusing anticoagulants into the blood, a blood filter including a substrate through which the blood is circulated and filtered, a fluid bag for storing the excess fluid and a blood outlet tube leading to a second blood vessel.
    Type: Grant
    Filed: December 11, 2009
    Date of Patent: June 26, 2012
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventors: Victor Gura, Edmond Rambod
  • Patent number: 8200313
    Abstract: Using Image-based Dynamic Ultrasound Spectrography (IDUSĀ®) technology, the intrabody monitoring and positioning of an inserted catheter is achieved by coupling a thin micron-size polymeric wire to the catheter with 100-500 micron metallic cylinder attached to the tip of the wire. The area of interest is imaged and subsequently stimulated using specialized stimulation schemes delivered by an imaging ultrasound transducer. The targeted metallic tip is stimulated and emanates a unique acoustic response (signature) corresponding to its mechanical and material properties. Because of the fundamental structural differences between the targeted metallic tip and its surroundings, its unique resonant frequency signature can be analyzed and differentiated relative to the surrounding soft tissue, the wire and the catheter itself so that the location of the catheter in the body can be determined.
    Type: Grant
    Filed: October 1, 2008
    Date of Patent: June 12, 2012
    Assignee: Bioquantetics, Inc.
    Inventors: Edmond Rambod, Daniel Weihs
  • Patent number: 8137299
    Abstract: An ultrafiltration device adapted to be worn on a portion of the body of a patient includes a blood inlet tube leading from a first blood vessel, a blood pump, an anticoagulant reservoir for infusing anticoagulants into the blood, a blood filter including a substrate through which the blood is circulated and filtered, a fluid bag for storing the excess fluid and a blood outlet tube leading to a second blood vessel.
    Type: Grant
    Filed: October 6, 2009
    Date of Patent: March 20, 2012
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventors: Victor Gura, Edmond Rambod
  • Patent number: 8109878
    Abstract: A method for detecting a target or targets in a medium. The method incorporates generating beams of ultrasonic wave energy each having a modulation envelope and causing each beam of wave energy to impact a target region having a multiplicity of targets and demodulating each signal generated by vibration of each target caused by the interaction of a respective ultrasound wave energy beam having a modulation envelope with each of the targets and receiving each demodulated signal from each target by a multiplicity of sensors. Thereafter, each time-of-flight of each demodulated signal from each of the targets to each of the multiplicity of sensors is computed to determine the location of a respective target.
    Type: Grant
    Filed: September 14, 2010
    Date of Patent: February 7, 2012
    Assignee: Quantason, LLC
    Inventors: Joseph O'Ruanaidh, David Steven Graff, Christopher J. Vecchio, Edmond Rambod, Robert M. Snukal
  • Patent number: 8109876
    Abstract: The present invention is a non-invasive method and apparatus to determine the structural integrity of an implanted BSCC by insonifying the implanted heart valve with a megahertz frequency to cause the structural components of the heart valve to vibrate at a kilohertz frequency range to cause the individual structural components of the heart valve being investigated to vibrate at their resonant frequency. From experimental testing, the Applicants have established resonant frequency ranges of certain structural components of the BSCC which indicate that at certain resonant frequency ranges the heart valve components are intact. At other resonant frequency ranges, certain components are in danger of breaking. At other frequency ranges, the components of the heart valve are fractured. Through the present invention, the condition of the BSCC can be determined in order to provide a clinical determination as to whether or not the implanted BSCC needs to be replaced.
    Type: Grant
    Filed: May 29, 2007
    Date of Patent: February 7, 2012
    Assignee: Bioquantetics, Inc.
    Inventors: Edmond Rambod, Morad Isaacian
  • Patent number: 8043217
    Abstract: Real-time Ultrasound Burst Spectrography (RUBS) is a technique in which a target is stimulated using a specialized ultrasound burst signal delivered by an imaging or non-imaging ultrasound transducer and the frequency spectrum of the resulting response is analyzed and studied. The objective of this method is to interrogate (vibrate) the target and then examine its characteristic response frequency (resonance) peaks, which are unique to its mechanical and material properties (viscosity, elasticity, plasticity, visco-elasticity, etc.). The resonances could deviate from a few Hz to several KHz and the response could be in the form of a narrow peak or a band of frequencies based on the stiffness coefficient of the target material. The primary goal is to develop a reliable and non-invasive ultrasound-based diagnostic device that can be used to identify different diseases or structural abnormalities based on the stationary or dynamic target's response frequency (resonance) to a specialized acoustic excitation.
    Type: Grant
    Filed: July 10, 2007
    Date of Patent: October 25, 2011
    Assignee: Bioquantetics, Inc.
    Inventor: Edmond Rambod
  • Publication number: 20110142700
    Abstract: A dual channel pulsatile pump for use with a completely wearable renal replacement device is provided.
    Type: Application
    Filed: November 15, 2010
    Publication date: June 16, 2011
    Applicant: Fresenius Medical Care Holdings, Inc.
    Inventors: Victor Gura, Edmond Rambod
  • Publication number: 20110125073
    Abstract: A continuous renal replacement therapy (CRRT) device is provided that weighs between 2 and 10 pounds. The CRRT device can be portable, mobile or completely worn on the person of the patient. Blood and dialysate are each pumped in a pulsed or pulsatile manner through a dialyzer such that a significant portion of the peak pulse of the blood flow coincides with a significant portion of a low pulse portion of the dialysate flow. An differential pressure between a dialysate inlet of the dialyzer and the blood inlet of the dialyzer periodically changes from a high differential pressure of between 70 and 120 mmHg for a first time period and a low differential pressure of between ?10 and 10 mmHg for a first time period and a low differential pressure of between ?10 and 10 mmHg for a second time period. The frequency of the high and low differential pressure cycle is between about 0.5 and 4 Hz.
    Type: Application
    Filed: December 23, 2010
    Publication date: May 26, 2011
    Inventors: Edmond Rambod, Victor Gura
  • Patent number: 7896829
    Abstract: A continuous renal replacement therapy (CRRT) device adapted to be worn on a portion of the body of a patient. The CRRT device is worn by the patient and operates on rechargeable batteries for more than 5 hours. Dialysate is used to remove impurities from the blood. The dialysate is recycled and refreshed by a filter section. Less than one liter of dialysate is required to circulate through the wearable CRRT device.
    Type: Grant
    Filed: February 9, 2007
    Date of Patent: March 1, 2011
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventors: Victor Gura, Edmond Rambod
  • Patent number: 7896830
    Abstract: An ultrafiltration device adapted to be worn on a portion of the body of a patient includes a blood inlet tube leading from a first blood vessel, a blood pump, an anticoagulant reservoir for infusing anticoagulants into the blood, a blood filter including a substrate through which the blood is circulated and filtered, a fluid bag for storing the excess fluid and a blood outlet tube leading to a second blood vessel.
    Type: Grant
    Filed: November 1, 2007
    Date of Patent: March 1, 2011
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventors: Victor Gura, Edmond Rambod
  • Patent number: 7892196
    Abstract: A continuous renal replacement therapy (CRRT) device adapted to be worn on a portion of the body of a patient. The CRRT device is worn by the patient and operates on rechargeable batteries for more than 5 hours. Dialysate is used to remove impurities from the blood. The dialysate is recycled and refreshed by a filter section. Less than one liter of dialysate is required to circulate through the wearable CRRT device.
    Type: Grant
    Filed: November 1, 2007
    Date of Patent: February 22, 2011
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventors: Victor Gura, Edmond Rambod
  • Patent number: 7871390
    Abstract: A continuous renal replacement therapy (CRRT) device is provided that weighs between 2 and 10 pounds. The CRRT device can be portable, mobile or completely worn on the person of the patient. Blood and dialysate are each pumped in a pulsed or pulsatile manner through a dialyzer such that a significant portion of the peak pulse of the blood flow coincides with a significant portion of a low pulse portion of the dialysate flow. An differential pressure between a dialysate inlet of the dialyzer and the blood inlet of the dialyzer periodically changes from a high differential pressure of between 70 and 120 mmHg for a first time period and a low differential pressure of between ?10 and 10 mmHg for a second time period. The frequency of the high and low differential pressure cycle is between about 0.5 and 4 Hz.
    Type: Grant
    Filed: November 19, 2007
    Date of Patent: January 18, 2011
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventors: Edmond Rambod, Victor Gura
  • Patent number: 7854718
    Abstract: A dual channel pulsatile pump for use with a completely wearable renal replacement device is provided.
    Type: Grant
    Filed: August 7, 2006
    Date of Patent: December 21, 2010
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventors: Victor Gura, Edmond Rambod
  • Patent number: 7828761
    Abstract: An ultrafiltration device adapted to be worn on a portion of the body of a patient includes a blood inlet tube leading from a first blood vessel, a blood pump, an anticoagulant reservoir for infusing anticoagulants into the blood, a blood filter including a substrate through which the blood is circulated and filtered, a fluid bag for storing the excess fluid and a blood outlet tube leading to a second blood vessel.
    Type: Grant
    Filed: July 30, 2007
    Date of Patent: November 9, 2010
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventors: Victor Gura, Edmond Rambod